Viewing Study NCT03169959


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-05-21 @ 12:14 PM
Study NCT ID: NCT03169959
Status: COMPLETED
Last Update Posted: 2017-08-14
First Post: 2017-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D168AC00001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View